1. Home
  2. TEVA vs WAT Comparison

TEVA vs WAT Comparison

Compare TEVA & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • WAT
  • Stock Information
  • Founded
  • TEVA 1901
  • WAT 1958
  • Country
  • TEVA Israel
  • WAT United States
  • Employees
  • TEVA N/A
  • WAT N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • WAT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • TEVA Health Care
  • WAT Industrials
  • Exchange
  • TEVA Nasdaq
  • WAT Nasdaq
  • Market Cap
  • TEVA 18.4B
  • WAT 21.9B
  • IPO Year
  • TEVA N/A
  • WAT 1995
  • Fundamental
  • Price
  • TEVA $13.65
  • WAT $321.01
  • Analyst Decision
  • TEVA Strong Buy
  • WAT Buy
  • Analyst Count
  • TEVA 6
  • WAT 15
  • Target Price
  • TEVA $24.00
  • WAT $393.13
  • AVG Volume (30 Days)
  • TEVA 12.0M
  • WAT 635.3K
  • Earning Date
  • TEVA 05-07-2025
  • WAT 05-06-2025
  • Dividend Yield
  • TEVA N/A
  • WAT N/A
  • EPS Growth
  • TEVA N/A
  • WAT N/A
  • EPS
  • TEVA N/A
  • WAT 10.71
  • Revenue
  • TEVA $16,544,000,000.00
  • WAT $2,958,387,000.00
  • Revenue This Year
  • TEVA $5.31
  • WAT $4.99
  • Revenue Next Year
  • TEVA $1.18
  • WAT $6.60
  • P/E Ratio
  • TEVA N/A
  • WAT $29.97
  • Revenue Growth
  • TEVA 4.41
  • WAT 0.07
  • 52 Week Low
  • TEVA $12.47
  • WAT $279.24
  • 52 Week High
  • TEVA $22.80
  • WAT $423.56
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 37.96
  • WAT 39.49
  • Support Level
  • TEVA $13.24
  • WAT $297.14
  • Resistance Level
  • TEVA $13.83
  • WAT $335.57
  • Average True Range (ATR)
  • TEVA 0.80
  • WAT 18.44
  • MACD
  • TEVA -0.03
  • WAT -1.05
  • Stochastic Oscillator
  • TEVA 38.44
  • WAT 32.60

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.

Share on Social Networks: